ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1685

Differential Impact of Cardiac Risk Factors On Coronary Plaque Presence and Features in Asymptomatic Patients with Rheumatoid Arthritis Compared to Controls

George A. Karpouzas1, Jennifer Malpeso2, Tae-Young Choi2, Silvia Munoz1 and Matthew Budoff2, 1Rheumatology, Harbor-UCLA, Torrance, CA, 2Cardiology, Harbor-UCLA Medical Center, Torrance, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects III: Rheumatoid Arthritis and Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Traditional cardiac risk factors (CRFs) associate with myocardial infarction (MI) risk in both Rheumatoid arthritis (RA) and the general population. Subclinical atherogenesis has been linked to higher risk of future clinical events. However, the independent role of individual CRFs on coronary plaque presence and characteristics in asymptomatic, coronary artery disease (CAD)-naïve subjects with RA is unknown. We evaluated potential differences in the contribution of traditional CRFs on coronary plaque presence, quantitative and qualitative features in asymptomatic subjects with RA compared to controls.

Methods: One hundred and fifty RA subjects and 150 age and sex-matched controls underwent 64-slice coronary computed tomography angiography (CTA), a modality that reliably evaluates plaque presence, severity, burden, and composition as non-calcified (NCP), mixed or partially calcified (MP), or fully calcified (CP). A 15-segment American Heart Association model was used for evaluation. Quantitative plaque characteristics included segment involvement score (SIS- number of affected segments out of 15 evaluated/ patient), segment stenosis score (SSS-degree of luminal stenosis per segment, graded 1-4 and averaged over 15 evaluated segments/ patient), and plaque burden score (PBS- plaque extent per segment, graded 1-3 and averaged over 15 segments/ patient). Logistic and multivariable regression analysis models adjusted for age, gender, and all CRFs were used to assess differences in plaque prevalence and quantitative measures, between groups.

Results: Quantitative plaque measurements were significantly higher in RA; SIS=2.02±2.28 vs. 0.9±1.25, SSS=3.03±4.43 vs. 0.98±1.7, and PBS= 2.75±3.82 vs. 0.98±1.44, all with p<0.0001. Hypertension was significantly and differentially associated with higher risk of plaque prevalence in RA [adjusted OR=4.3 (1.83-10.1)- figure 1a]. Additionally, in the context of RA, the presence of male gender, hypertension and diabetes were associated with higher mean differences in the proportion of involved segments, plaque severity, and burden vs. their absence, compared to those imparted in controls (all with p<0.05- figure 1b, c, d respectively). Importantly, these differences segregated exclusively in MP and CP but not NCP.

Conclusion: Hypertension strongly and differentially associates with coronary plaque presence in CAD-naïve, asymptomatic subjects with RA compared to controls. In RA, male gender, hypertension and diabetes are associated with significant differences in plaque severity, burden and number of involved segments compared to presence of those factors in controls, specifically for MP and CP.

 

 


Disclosure:

G. A. Karpouzas,
None;

J. Malpeso,
None;

T. Y. Choi,
None;

S. Munoz,
None;

M. Budoff,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-impact-of-cardiac-risk-factors-on-coronary-plaque-presence-and-features-in-asymptomatic-patients-with-rheumatoid-arthritis-compared-to-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology